WallStreetZenWallStreetZen

NASDAQ: ACRS
Aclaris Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Aclaris Therapeutics earnings were -$58.7M for the trailing 12 months ending Jun 30, 2024, with N/A growth year over year. The latest ACRS earnings report on Jun 30, 2024 announced Q2 2024 earnings of -$11.0M, down 35.2% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, ACRS reported annual earnings of -$88.5M, with 1.8% growth. The next ACRS earnings date is Nov 4, 2024.

ACRS earnings history

Current Revenue
$32.0M
Current Earnings
-$58.7M
Current Profit Margin
-183.3%

ACRS Return on Equity

Current Company
-39.8%
Current Industry
-12.9%
Current Market
33.7%
ACRS's Return on Equity (-39.8%)... subscribe to Premium to read more.
High Return on Equity Performance

ACRS Return on Assets

Current Company
-31.3%
Current Industry
6%
ACRS is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ACRS announces earnings.

ACRS Return on Capital Employed

Current Company
-40.61%
Current Industry
14.1%
ACRS's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ACRS vs Diagnostic & Research Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ACRS-$58.11M-$58.68MN/A-$0.82
VNRX-$30.78M-$32.42MN/A-$0.40
FONR$24.72M$9.91M-7.15%$1.56
ENZ$44.83M$44.73M+87.22%$0.92
PREN/A-$62.99MN/A-$5.42
View Top Diagnostic & Research Stocks

ACRS earnings dates

Next earnings date
Nov 4, 2024

Aclaris Therapeutics Earnings Reports & History FAQ

What were Aclaris Therapeutics's earnings last quarter?

On ACRS's earnings call on Invalid Date, Aclaris Therapeutics (NASDAQ: ACRS) reported Q2 2024 earnings per share (EPS) of -$0.15, up 64.29% year over year. Total ACRS earnings for the quarter were -$10.99 million. In the same quarter last year, Aclaris Therapeutics's earnings per share (EPS) was -$0.42.

If you're new to stock investing, here's how to buy Aclaris Therapeutics stock.

When does Aclaris Therapeutics report earnings?

The next ACRS earnings call is Invalid Date. Add ACRS to your watchlist to be reminded of Aclaris Therapeutics's next earnings date.

Is Aclaris Therapeutics profitable or losing money?

As of the last Aclaris Therapeutics earnings report, Aclaris Therapeutics is currently losing money. Aclaris Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2024 was -$58.68 million, a 44.28% decrease year over year.

What was ACRS's earnings growth in the past year?

As of Aclaris Therapeutics's earnings date in Invalid Date, Aclaris Therapeutics's earnings has grown year over year. ACRS earnings in the past year totalled -$58.68 million.

What are Aclaris Therapeutics's earnings expectations?

The current EPS estimate for Aclaris Therapeutics's earnings report in Invalid Date is -$0.01.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.